WindMIL Therapeutics Expands Leadership Team
BALTIMORE and PHILADELPHIA, Jan. 07, 2020 (GLOBE NEWSWIRE) -- WindMIL Therapeutics, a clinical-stage company developing marrow-infiltrating lymphocytes (MILs™) for cancer immunotherapy, today announced the expansion of its leadership team with the …